Search JIM Advanced Search

Journal of Chinese Integrative Medicine ›› 2008, Vol. 6 ›› Issue (7): 720-724.doi: 10.3736/jcim20080712

• Original Experimental Research • Previous Articles     Next Articles

Scutellaria barbata extract enhances efficacy and reduces toxicity of chemotherapy in hepatoma H22-bearing mice

Zhi-jun Dai1(), Xi-jing Wang1, Zong-zheng Ji2, Zong-fang Li2, Wei Tang3, Hua-feng Kang1, Xiao-bin Ma1, Lei Liu1   

  1. 1. Department of Oncology,Second Hospital,School of Medicine,Xi’an Jiaotong University,Xi’an,Shannxi Province 710004, China;
    2. Department of General Surgery, Second Hospital, School of Medicine, Xi’an Jiaotong University,Xi’an,Shannxi Province 710004, China;
    3. Department of Life Science, Shannxi Normal University, Xi'an, Shannxi Province 710062, China
  • Received:2007-10-13 Online:2008-07-20 Published:2008-07-15
  • Contact: DAI Zhi-jun

Objective: To study the assistant effect of Scutellaria barbata extract (ESB) in 5-fluorouracil (5-FU) chemotherapy.
Methods: A mouse model of transplanted hepatoma H22 was used in this study to evaluate the synergic and attenuating effects of ESB in chemotherapy. Tumor inhibition rate, life span of mice and the toxicity of chemotherapy were observed. The body weight, tumor weight, thymus index and spleen index in H22-bearing mice were also measured. The phagocytotic function of macrophages was studied by observing phagocytiz-ation of peritoneal macrophages.
Results: The increase of body weight in 5-FU plus ESB groups was higher than that in 5-FU group, and the side effects such as anorexia, abdominal distention and athrepsy were relieved. Compared with untreated group, prolonged lifetime in 5-FU plus high-dose ESB group and 5-FU plus low-dose ESB group was improved. Life prolongation rates in 5-FU plus high-dose ESB group and 5-FU plus low-dose ESB group were 61.46% and 23.59% respectively. High-dose ESB, 5-FU, 5-FU plus low-dose ESB and 5-FU plus high-dose ESB could inhibit the tumor growth, and the tumor inhibition rates were 36.98%, 42.26%, 52.45% and 65.28%, respectively. Thymus index and spleen index were increased significantly in 5-FU plus low-dose ESB group and 5-FU plus high-dose ESB group. White blood cell (WBC) count was decreased obviously in 5-FU group, while the count of WBC was increased in 5-FU plus low-dose ESB group and 5-FU plus high-dose ESB group. The phagocytotic function of macrophages was also increased in 5-FU plus low-dose ESB group and 5-FU plus high-dose ESB group.
Conclusion: ESB can enhance the effect of chemotherapy, relieve the side effects and improve immune function of mice in chemotherapy. These results suggest that ESB, as a biochemical modulator to enhance the therapeutic effects, is useful in cancer chemotherapy.

Key words: Scutellaria barbata, liver cancer, immunity, chemotherapy, mice

CLC Number: 

  • R735.7

Table 1

Effect of ESB on body weight in H22 solid tumor-bearing mice ($\bar{x}$±s, g)"

Group n Body weight
Pre-treatment Post-treatment Variation of body weight
Normal control 10 20.03±1.94 24.12±2.02 4.09±2.32
Untreated 10 20.03±2.07 23.50±3.24 3.47±3.82
Low-dose ESB 10 20.00±1.94 24.52±1.82 4.52±3.93
High-dose ESB 10 20.01±2.10 25.15±2.13 5.14±3.76△▲
5-FU 10 19.96±2.03 20.74±1.86 0.78±1.93
5-FU plus low-dose ESB 10 20.00±2.13 22.46±1.92 2.46±1.62
5-FU plus high-dose ESB 10 19.98±2.05 24.33±2.05 4.35±3.25△▲

Table 2

Effects of ESB on life-prolonging rate and tumor inhibition rate in H22-bearing mice ($\bar{x}$±s )"

Group n Ascites tumor-bearing mice Solid tumor-bearing mice
Survival time (d) Life-prolonging rate (%) Tumor weight (g) Tumor inhibition rate (%)
Normal control 10
Untreated 10 16.32±4.92 2.65±1.12
Low-dose ESB 10 18.47±5.23 13.17 2.27±0.93 14.34
High-dose ESB 10 24.65±5.80△▲ 51.04 1.67±0.76 36.98
5-FU 10 13.26±4.15 -3.72 1.53±0.64 42.26
5-FU plus low-dose ESB 10 20.17±4.54 23.59 1.26±0.45 52.45
5-FU plus high-dose ESB 10 26.35±5.65△▲ 61.46 0.92±0.58△▲ 65.28

Table 3

Effects of ESB on thymus index, spleen index and WBC count in H22 solid tumor-bearing mice ($\bar{x}$±s )"

Group n Thymus index (mg/g) Spleen index (mg/g) White blood cell count (109/L)
Normal control 10 3.64±2.03 5.67±2.37 9.08±0.74
Untreated 10 2.47±0.68* 3.82±2.32* 8.78±0.68
Low-dose ESB 10 2.62±1.54 4.25±1.92 8.82±0.59
High-dose ESB 10 3.65±2.36△▲ 5.44±3.06△▲ 9.16±0.70
5-FU 10 1.43±0.56 2.92±1.73 5.15±0.52
5-FU plus low-dose ESB 10 2.55±1.32 3.96±1.65 7.62±0.64
5-FU plus high-dose ESB 10 3.16±2.15 4.72±2.02 8.47±0.58

Table 4

Effect of ESB on phagocytotic function of macrophages in H22 solid tumor-bearing mice ($\bar{x}$±s )"

Group n Phagocytizing rate (%) Phagocytizing index
Normal control 10 45.83±3.33 0.94±0.04
Untreated 10 38.52±3.16 0.73±0.04
Low-dose ESB 10 41.32±3.05 0.79±0.05
High-dose ESB 10 47.46±3.55△▲ 0.93±0.06△▲
5-FU 10 22.47±2.12 0.49±0.03
5-FU plus low-dose ESB 10 32.35±2.53 0.71±0.06
5-FU plus high-dose ESB 10 40.12±3.68 0.89±0.05
[1] Yin X, Zhou J, Jie C , et al. Anticancer activity and mechanism of Scutellaria barbata extract on human lung cancer cell line A549[J]. Life Sci, 2004,75(18):2233-2244
doi: 10.1016/j.lfs.2004.05.015
[2] Lin JM, Liu Y, Luo RC . Inhibition activity of Scutellariae barbata extracts against human hepatocellular carcinoma cells[J]. Nan Fang Yi Ke Da Xue Xue Bao, 2006,26(5):591-593
doi: 10.3321/j.issn:1673-4254.2006.05.014
林敬明, 刘煜, 罗荣城 . 半枝莲抑制人肝癌QGY-7701细胞增殖研究[J]. 南方医科大学学报, 2006,26(5):591-593
doi: 10.3321/j.issn:1673-4254.2006.05.014
[3] Ye J, Xu XK, Zhou JW , et al. Prevention and treatment of herba Scutellariae barbatae compound on diethylnitrosamine induced hepatocarcinoma of rat[J]. Zhongguo Zhong Xi Yi Jie He Xiao Hua Za Zhi, 2002,10(2):67-80
doi: 10.3969/j.issn.1671-038X.2002.02.001
叶健, 徐锡坤, 周建伟 , 等. 半枝莲防治二乙基亚硝胺诱发大鼠肝癌的研究[J]. 中国中西医结合消化杂志, 2002,10(2):67-80
doi: 10.3969/j.issn.1671-038X.2002.02.001
[4] Chen Z, Wang P, Huang WX , et al. Experimental study on effects of Shengmai Injection: enhancing 5-FU anti-tumor efficacy and reducing its toxicity[J]. Zhong Xi Yi Jie He Xue Bao, 2005,3(6):476-479
陈震, 王鹏, 黄雯霞 , 等. 生脉注射液对5-FU增效减毒作用的实验研究[J]. 中西医结合学报, 2005,3(6):476-479
[5] Wu SL, Sun ZJ, Yu L , et al. Effect of resveratrol and in combination with 5-FU on murine liver cancer[J]. World J Gastroenterol, 2004,10(20):3048-3052
doi: 10.1111/j.1365-2036.2004.02175.x pmid: 15378791
[6] Cao Y, Xia QH, Meng H , et al. Antitumor and synergistic effect of Chinese medicine bushen huayu jiedu recipe and chemotherapy on transplanted animal hepatocarcinoma[J]. World J Gastroenterol, 2005,11(33):5218-5220
[7] Li XJ, Mao YX, Zhang HL , et al. Study on effects of anticancer and immunoregulation of Fuganchun 6 on hepatoma of mouse[J]. Zhongguo Zhong Yao Za Zhi, 2006,31(19):1622-1625
李秀娟, 毛宇湘, 张焕铃 , 等. 复肝春6号对小鼠肝癌的抑制作用及对荷瘤小鼠免疫功能的影响[J]. 中国中药杂志, 2006,31(19):1622-1625
[8] Liu MH, Zhang Z, Gu L , et al. Effects of powders of Wu Shi Bai Ye San(WSBRYS) for the tumor growth and immune function in tumor bearing mice[J]. Zhongguo Xin Yao Za Zhi, 2006,15(3):201-204
doi: 10.3321/j.issn:1003-3734.2006.03.009
刘明华, 章卓, 顾立 , 等. 伍氏百叶散对荷瘤小鼠肿瘤生长及免疫功能的影响[J]. 中国新药杂志, 2006,15(3):201-204
doi: 10.3321/j.issn:1003-3734.2006.03.009
[9] Wang G, Dong M, Liu XS , et al. Anti-tumor activity study of extract from Scutellaria barbata D. Don[J]. Xian Dai Zhong Xi Yi Jie He Za Zhi, 2004,13(9):1141-1142
doi: 10.3969/j.issn.1008-8849.2004.09.010
王刚, 董玫, 刘秀书 , 等. 半枝莲醇提物抗肿瘤活性的研究[J]. 现代中西医结合杂志, 2004,13(9):1141-1142
doi: 10.3969/j.issn.1008-8849.2004.09.010
[10] Wang WS, Zhou YW, Ye YH , et al. Studies on the flavonoids in herb from Scutellaria barbata[J]. Zhongguo Zhong Yao Za Zhi, 2004,29(10):957-959
doi: 10.3321/j.issn:1001-5302.2004.10.009
王文蜀, 周亚伟, 叶蕴华 , 等. 半枝莲中黄酮类化学成分研究[J]. 中国中药杂志, 2004,29(10):957-959
doi: 10.3321/j.issn:1001-5302.2004.10.009
[1] Yi Ran Hu, San Li Xing, Chuan Chen, Ding Zhu Shen, Jiu Lin Chen. Tiaoxin Recipe, a Chinese herbal formula, inhibits microRNA-34a expression in the APPswe/PS1ΔE9 mouse model of Alzheimer's disease. Journal of Integrative Medicine, 2019, 17(6): 404-409.
[2] Chang-quan Ling, Jia Fan, Hong-sheng Lin, Feng Shen, Zhen-ye Xu, Li-zhu Lin, Shu-kui Qin, Wei-ping Zhou, Xiao-feng Zhai, Bai Li, Qing-hui Zhou, on behalf of the Chinese Integrative Therapy of Primary Liver Cancer Working Group. Clinical practice guidelines for the treatment of primary liver cancer with integrative traditional Chinese and Western medicine. Journal of Integrative Medicine, 2018, 16(4): 236-248.
[3] Marco Cascella, Maria Rosaria Muzio. Potential application of the Kampo medicine goshajinkigan for prevention of chemotherapy-induced peripheral neuropathy. Journal of Integrative Medicine, 2017, 15(2): 77-87.
[4] Bhesh Raj Sharma, Dong Wook Kim, Dong Young Rhyu. Korean Chungtaejeon tea extract attenuates weight gain in C57BL/6J-Lep ob/ob mice and regulates adipogenesis and lipolysis in 3T3-L1 adipocytes. Journal of Integrative Medicine, 2017, 15(1): 56-63.
[5] Yu-fangLin, Zhi-danLiu, WenMa, Wei-dongShen. Hazards of insomnia and the effects of acupuncture treatment on insomnia. Journal of Integrative Medicine, 2016, 14(3): 174-186.
[6] Shi-li Jiang, Xu-dong Hu, Ping Liu. Immunomodulation and liver protection of Yinchenhao decoction against concanavalin A-induced chronic liver injury in mice. Journal of Integrative Medicine, 2015, 13(4): 262-268.
[7] Elizabeth Abidemi Balogun, Sylvia Orume Malomo, Joseph Oluwatope Adebayo, Ahmed Adebayo Ishola, Ayodele Olufemi Soladoye, Lawrence Aderemi Olatunji, Olatunji Matthew Kolawole, Stephen Olubunmi Oguntoye, Abiola Samuel Babatunde, Oluwole Busayo Akinola . In vivo antimalarial activity and toxicological effects of methanolic extract of Cocos nucifera (Dwarf red variety) husk fibre. Journal of Integrative Medicine, 2014, 12(6): 504-511.
[8] Zhi-yi Zhou, Ling Xu, He-gen Li, Jian-hui Tian, Li-jing Jiao, Sheng-fu You, Zhi-fen Han, Yi Jiang, Hui-ru Guo​, Hui Liu​. Chemotherapy in conjunction with traditional Chinese medicine for survival of elderly patients with advanced non-small-cell lung cancer: Protocol for a randomized double-blind controlled trial. Journal of Integrative Medicine, 2014, 12(3): 175-181.
[9] Md. Asadujjaman, Ahmed Ullah Mishuk, Md. Aslam Hossain, Utpal Kumar Karmakar. Medicinal potential of Passiflora foetida L. plant extracts: Biological and pharmacological activities. Journal of Integrative Medicine, 2014, 12(2): 121-126.
[10] Marjan Nassiri-Asl, Taghi Naserpour Farivar, Esmail Abbasi, Hamid Reza Sadeghnia, Mehdi Sheikhi, Mina Lotfizadeh, Parisa Bazahang. Effects of rutin on oxidative stress in mice with kainic acid-induced seizure. Journal of Chinese Integrative Medicine, 2013, 11(5): 337-342.
[11] Md. Khirul Islam, Imran Mahmud, Sanjib Saha, Asit Baron Sarker, Himangsu Mondal, A.S.M. Monjur-Al-Hossain, Md. Anisuzzman. Preliminary pharmacological evaluation of Alocasia indica Schott tuber. Journal of Chinese Integrative Medicine, 2013, 11(5): 343-351.
[12] Sanjib Saha, Faroque Hossain, Md. Anisuzzman, Md. Khirul Islam. Pharmacological evaluation of Musa seminifera Lour. Fruit. Journal of Chinese Integrative Medicine, 2013, 11(4): 253-261.
[13] Sunil A. Nirmal, Jayashri M. Ingale, Shashikant R. Pattan, Sanjay B. Bhawar. Amaranthus roxburghianus root extract in combination with piperine as a potential treatment of ulcerative colitis in mice. Journal of Chinese Integrative Medicine, 2013, 11(3): 206-212.
[14] Lin Wang, Guan-liang Wang, Jia-han Liu, Di Li, De-zeng Zhu, Liang-neng Wu . Effects of ursolic acid in ameliorating insulin resistance in liver of KKAy mice via peroxisome proliferator-activated receptors α and γ. Journal of Chinese Integrative Medicine, 2012, 10(7): 793-799.
[15] Yi-tao Zhao , Xin-guang Zhang , Li Bai , Li-qing Li , Jian-er Yu . Effects of Chinese herbal medicine Pingchuan Formula on airway inflammation, interferon-γ and interleukin-4 in mice with asthma. Journal of Chinese Integrative Medicine, 2012, 10(7): 807-813.
Full text



[1] Jun Hu, Jian-ping Liu. Non-invasive physical treatments for chronic/recurrent headache. Journal of Chinese Integrative Medicine, 2008, 6(1): 31
[2] Jun Cai, Hua Wang, Sheng Zhou, Bin Wu, Hua-rong Song, Zheng-rong Xuan. Effect of Sijunzi Decoction and enteral nutrition on T-cell subsets and nutritional status in patients with gastric cancer after operation: A randomized controlled trial. Journal of Chinese Integrative Medicine, 2008, 6(1): 37-40
[3] Xue-mei Liu, Qi-fu Huang, Yun-ling Zhang, Jin-li Lou, Hong-sheng Liu, Hong Zheng. Effects of Tribulus terrestris L. saponion on apoptosis of cortical neurons induced by hypoxia-reoxygenation in rats. Journal of Chinese Integrative Medicine, 2008, 6(1): 45-50
[4] Guo-hong Yuan, Xiao-jing Pang, He-chao Ma. Synergic effects of Danggui Buxue Decoction in reducing toxicity of cytoxan in tumor-bearing mice. Journal of Chinese Integrative Medicine, 2008, 6(1): 83-88
[5] Xin-jun Wang, Ling-ling Wang . A mechanism of endogenous opioid peptides for rapid onset of acupuncture effect in treatment of depression. Journal of Chinese Integrative Medicine, 2010, 8(11): 1014-1017
[6] Bo Wang , Wei Yan , Li-hui Hou, Xiao-ke Wu. Disorder of Tiangui (kidney essence) and reproductive dysfunction in patients with polycystic ovary syndrome. Journal of Chinese Integrative Medicine, 2010, 8(11): 1018-1022
[7] Bing Hu , Hong-mei An , Ke-ping Shen , Qin Du. Senescence-inducing effects of Chinese herbal medicine Tenglong Buzhong Decoction on human colon carcinoma LS-174-T cells and the mechanism. Journal of Chinese Integrative Medicine, 2010, 8(11): 1048-1052
[8] Jing-yuan Mao, Chang-xiao Liu, Heng-he Wang, Guang-li Wei , Zhen-peng Zhang, Jie Xing, Wang Xian liang , Ying-fei Bi . Effects of Shenmai Injection on serum concentration and pharmacokinetics of digoxin in dogs with heart failure. Journal of Chinese Integrative Medicine, 2010, 8(11): 1070-1074
[9] Zhi-mei Wang, Bin Zhang. A study on translation of ellipses in Huangdi Neijing from perspective of hermeneutic theory. Journal of Chinese Integrative Medicine, 2010, 8(11): 1097-1100
[10] Hui-min Liu, Xian-bo Wang, Yu-juan Chang, Li-li Gu. Systematic review and meta-analysis of randomized controlled trials of integrative medicine therapy for treatment of chronic severe hepatitis. Journal of Chinese Integrative Medicine, 2012, 10(11): 1211-1228